GBT Stock: Why Pfizer's $5.4 Billion Takeover Is 'Mutually Beneficial' | Investor's Business Daily – Investor's Business Daily
Business News
- GBT Stock: Why Pfizer’s $5.4 Billion Takeover Is ‘Mutually Beneficial’ | Investor’s Business Daily Investor’s Business Daily
- Pfizer to buy Global Blood Therapeutics in $5.4 billion deal CNBC
- Pfizer spends billions on another takeover Reuters
- Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics The Wall Street Journal
- Pfizer buying spree continues with $5.4B hematology deal The Associated Press – en Español
- View Full Coverage on Google News
Source: Business News